TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 23
- Q3 2024, +3 vs. previous quarter
- 13F value
- $1.48M
- Reported value at the end of Q3 2024
- Superinvestors holding
- 0
- At the end of Q3 2024
Superinvestors holding TFFP, Q3 2024
No superinvestor reported holding TFFP at the end of Q3 2024.
Latest insider trades
Open-market purchases and sales by TFF Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 (view filing)5:29 PM ET | Aug 15 | 2 days | Carlson Capital, L.P. and 3 others10% Owner | SSaleCommon Stock, par value $0.001 per share (the "Common Stock" | −215.0K | $0.4374 | −$94.0K | −4.1%5.07M after | |
| Aug 17, 2023 (view filing)5:29 PM ET | Aug 16 | 1 day | Carlson Capital, L.P. and 3 others10% Owner | SSale | −1.00K | $0.3916 | −$391.6 | 0.0%5.06M after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Weisman Harlan FPresident and CEO | PPurchase | +600.0K | $0.25 | +$150.0K | +279.6%814.6K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Rocamboli StephenDirector | PPurchase | +20.0K | $0.25 | +$5.00K | +125.0%36.0K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Roberts BrandiDirector | PPurchase | +20.0K | $0.25 | +$5.00K | New position20.0K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Coleman Kirk AllenChief Financial Officer | PPurchase | +20.0K | $0.25 | +$5.00K | +127.6%35.7K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Mills Robert SDirector | PPurchase | +40.0K | $0.25 | +$10.0K | +250.3%56.0K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Mikhak ZamanehChief Medical Officer | PPurchase | +120.0K | $0.25 | +$30.0K | +800.0%135.0K after | |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | Rocamboli StephenDirector | PPurchase | +13.0K | $0.80 | +$10.4K | +433.3%16.0K after | |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | Coleman Kirk AllenChief Financial Officer | PPurchase | +12.0K | $0.79 | +$9.48K | +326.5%15.7K after |
Top 10 13F holders, Q3 2024
The largest institutional positions in TFF Pharmaceuticals, Inc. at the end of Q3 2024; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carlson Capital L P | 293,460 | $589.9K | 0.36% | 00.0% | Unchanged |
| Armistice Capital, LLC | 228,000 | $458.3K | 0.01% | +42,305+22.8% | Added |
| Westside Investment Management, Inc. | 75,264 | $151.3K | 0.03% | +24,773+49.1% | Added |
| DRW Securities, LLC | 40,000 | $80.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 27,999 | $56.3K | 0.00% | +6,201+28.4% | Added |
| Renaissance Technologies LLC | 20,497 | $41.2K | 0.00% | +5,720+38.7% | Added |
| Citadel Advisors LLC | 13,579 | $27.3K | 0.00% | +13,579 | New |
| Vanguard Group Inc | 12,136 | $24.4K | 0.00% | 00.0% | Unchanged |
| Nwam LLC | 10,240 | $20.6K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 7,186 | $14.4K | 0.00% | +7,186 | New |
Congress trades
1 member of Congress reported 2 trades in TFF Pharmaceuticals, Inc. since 2020. Newest filings:
| Filed | Member | Type | Amount |
|---|---|---|---|
| Aug 26, 2021 | Tom MalinowskiDemocrat · House · NJ | Buy | $1K-$15K |
| Mar 5, 2021 | Tom MalinowskiDemocrat · House · NJ | Buy | $1K-$15K |
Democrat · House · NJ · Aug 26, 2021
Buy$1K-$15K
Democrat · House · NJ · Mar 5, 2021
Buy$1K-$15K